Wednesday, 16th November Joint 2016 COSA and ANZBCTG Annual Scientific Meeting

Many researchers and research organisations recognise the value of engaging with consumers with the consistent message being that people who have a personal experience of cancer bring a unique perspective and a wealth of diversity, knowledge, and capabilities to research and health initiatives. In addition, funding bodies almost always insist on researchers demonstrating this perspective has been sought for applications to be considered favourably. However, some hesitation still exists and connecting effectively is often easier said than done. Can a lay person really understand research concepts and provide meaningful input? This session will provide examples of working partnerships and what it takes for individual researchers, research organisations, and consumers to work collaboratively to bring better health outcomes for people affected by cancer. 

This breakfast session is supported by COSA and ANZBCTG

Chair: Rick de Boer

Neoadjuvant treatment of breast cancer is becoming an integral part of modern multidisciplinary cancer management. Join us for breakfast with international expert Dr Laura Esserman, as she covers the clinical evidence and more practical aspects of neoadjuvant treatment in HER2-positive breast cancer. Following this, a multidisciplinary panel will discuss how this evidence translates in to clinical practice in Australia, now and in to the future.

Governments throughout the world are exploring ways by which affordable access to innovative cancer medicines can be expedited. A number of years ago Canada implemented a specialised pan-Canadian Oncology Drug Review (pCODR), outside of the regular reimbursement process. Bill Evans is an oncologist and former member of the pCODR Expert Review Committee (pERC). This symposium will be an opportunity to examine some of the challenges for access to medicines in Australia, and understand how clinicians can play a role in supporting timely and affordable cancer treatment.

Speakers:
Dr Bill Evans - former member of Pan-Canadian Oncology Drugs Review
Dr Deme Karikios - Medical Oncology Group of Australia
Others TBC

• Targeting therapeutic resistance in HER2-positive breast cancer - Shom Goel
• Translating Molecular Insights in Estrogen Receptor signalling into Clinical Trials in Breast Cancer - Elgene Lim
• Drug Interactions with targeted Therapies - Gail Rowan
• Nursing management in advanced disease - Jenny Gilchrist

10:10 AM Panel Discussion

• Male Breast Cancer: The Challenges - John Boyages
• Hormonal treatments after male breast cancer - Nicholas Wilcken
• Psychological Issues in Male Breast Cancer - Jemma Gilchrist
• Male breast cancer: could I have faulty gene? - Judy Kirk

11:40 AM Interviews with MBC patients Herb Wagner (founder "A Man's Pink") and Robert Fincher  (BCNA)

12:00 PM Q&A panel discussion

• Clinical trials in the international neo adjuvant setting - Laura Esserman
• Neoadjuvant Breast Cancer Clinical Trials in Australia - Prudence A Francis
• Decision aids, patient views and barriers - Nicholas Zdenkowski
• The role of specialist nurses in supporting the patient undergoing neo adjuvant therapies - Janine Porter-Steele

• Pain in cancer survivors - Paul Glare
• Physiotherapy strategies for cancer pain  - Sharni Patchell
• Self-management of chronic malignant pain - Anthony Hall
• Australian Cancer Pain guidelines - Melanie Lovell

12:15 PM  Cancer pain and the MDT panel discussion

• Weight Loss Trials in Women Diagnosed with Breast Cancer - Melinda Irwin
• Living well after breast cancer: can we improve outcomes for breast cancer patients through weight management? - Marina Reeves
• Investigating the association of alcohol with breast cancer recurrence and the way in which alcohol recommendations are discussed between clinicians and oncology patients - Phanthira Simapivapan
• Standardized ginger extract  improves quality of life associated with chemotherapy-induced nausea and vomiting - Wolfgang Marx

This session follows a highly successful format used at previous meetings. It is designed to provide a forum for discussion of the complex issues which arise in the care of patients with breast cancer. The facilitator will present a series of challenging clinical cases and engage members of the multidisciplinary panel in discussion. There will also be opportunities for members of the audience to contribute to the discussion.

Panellists include:

- Boon Chua – Radiation oncologist
- Laura Esserman – Surgeon
- Sunil Lakhani – Translational researcher
- Kelly Phillips – Medical oncologist
- Janine Porter-Steele – Nurse
- Michelle Reintals – Radiologist
- Claudia Rutherford – Research Fellow, Quality of Life
- Leonie Young - Consumer

• Impact of tumour infiltrating lymphocytes (TILs) & tumour regression in primary cutaneous melanoma on response to Immune Checkpoint Inhibitor (ICI) therapy - Michelle Mcmullen
• Investigating the HER2-3 dimer as a theranostic target in brain metastases - Jodi M Saunus
• Establishment of new methods to quantify the mu-opioid and TLR-4 receptor activation potential in biological samples to assess the influence of opioids on tumour metastasis - Nan Xie
• Follow up of indeterminate lung nodules on PET-CT  scan in patient with lung cancer treated with curative intent : Retrospective study - Pawan Bajaj
• Assessing the impact of chemotherapy-induced peripheral neuropathy in Australia via a patient survey - Eva Battaglini
• Understanding initiation of nutrition support in patients with head and neck cancer (HNC) and adherence to recommendations– a patient perspective - Teresa Brown
• Report on a Consecutive Series of Ipilimumab Treated Metastatic Melanoma Patients at a Single Australian Institution - Rachael Chang
• Pneumocystis pneumonia (PJP) in lung cancer patients - Nuttaya Chavalertsakul
• Frequency of venous thromboembolism and its association to Khorana risk score in patients receiving chemotherapy at Goulburn Valley Health - Patrick Dhar
• Electronic MDT Workflow - Brett J Fielding
• Parkinsonism and encephalopathy associated with Pembrolizumab: A case report. - Aaron Gaekwad
• Sexual inactivity among female cancer survivors - Martha Hickey
•  Cancer Registry Data on the initial 389 cancer patients seen at Aga Khan Hospital, a private hospital in Dar es Salaam, Tanzania. - Aleesha AA Kurbanali Adatia
• A single centres experience of cardiac metastasis from neuroendocrine tumours (NET). - Rahul Ladwa
• Mortality within 30 days of receiving chemotherapy for malignant pleural mesothelioma in a single metropolitan oncology unit - Wei-Sen WSL Lam
• Preliminary results from an ongoing prospective cohort study of scalp hypothermia in the prevention of chemotherapy induced alopecia in rural New South Wales - Dean B Letchford
• An Australian experience of the use of Uridine Triacetate (Vistogard®) antidote for severe capecitabine toxicity- A Case Report - Louisa L Lo
• Clinicopathological correlates of colorectal cancer (CRC) in young patients: An Australian Institution Experience - Jennifer T Man
• Angiocentric glioma transformed into anaplastic ependymoma. Evidence of a pleomorphic tumour capable of ependymal and glial transformation? - James McCracken
• Clinician and nurse reporting habits for chemotherapy-induced peripheral neuropathy - J. Matt McCrary
• An update of the tolerability and feasibility of newer adjuvant chemotherapy in older patients with breast cancer. - Rahul Ladwa
• Two-year overall survival (OS) rates from a randomized phase 2 trial evaluating the combination of nivolumab (NIVO) and ipilimumab (IPI) versus IPI in patients with advanced melanoma (MEL) - Michael A Postow
• Is there a correlation between AMH and menses resumption after breast cancer treatment? - Genia Rozen
• Outcome of patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer - Babak Tamjid
• Evaluation of a weight management program for overweight and obese cancer survivors. - Jane D Turner
• More than a decade of giving neoadjuvant chemotherapy in an Australian breast cancer setting: what have we learned? - Belinda Yeo
• Phase 2 Study of Lenvatinib in Patients With Differentiated, Medullary, and Anaplastic Thyroid Cancer: Final Analysis Results - Louise Young
• A review of everolimus-exemestane combination treatment in metastatic breast cancer – A real-world clinical experience. - Anupriya Agarwal
• Acceptability of an innovative funding model for breast cancer research and patient support - Jenny O Anderson
• Assessing patient suitability for risk-reducing mastectomy: a psychologist’s role. - Lucy Braude
• A survey of Australian and New Zealand clinical use of antiresorptive therapy in metastatic breast cancer - Robert Campbell
• Women's preferences for avoiding cancer recurrence:  a focus on contralateral prophylactic mastectomy - Richard De Abreu Lourenco
• Role Ambiguity in SBN practice in Rural and Regional Queensland results in variations of service delivery. - Pammie Ellem
• Carcinoma en cuirasse: A rare presentation of breast cancer – a case report - Jenny Gilchrist
• Slip and Slide: Findings from the Sexual Activity after Breast Cancer (SAB) Study - Martha Hickey
• Clinical guidance for management of lobular carcinoma in situ - Briony Jack
• Implementing a standardized breast cancer database in a private hospital in Western Australia – a pilot study - Niloufer J Johansen
• What women with metastatic breast cancer want in an internet-intervention for cancer-related distress: A qualitative exploration. - Emma Kemp
• Label-free Enrichment and Integrated mRNA-Sequencing Analysis of Single Circulating Tumour Cells from Blood Sample - Yifang Lee
• Toxicity and Adherence to Adjuvant Anti-estrogens and the Utility of Switching to Second-line Agents - Hilary L Martin
• Breast Cancer Clinical Quality Indicators - Graham Pitson
• Content analysis of clinical letters for breast cancer patients in the adjuvant setting – the first step towards automated extraction of clinical data - Graham Pitson
• Multidisciplinary meetings in the treatment of breast cancer - Graham Pitson
• Guideline-adherent treatment for women with breast cancer: do they receive what the multidisciplinary team recommend and does this affect survival - Neli Slavova-Azmanova
•  Axillary Web Syndrome and Trunk Cording Case Studies: Treatments, Procedures and Outcomes. - Denise Stewart
• Overall dietary intake and prognosis after breast cancer: a systematic review - Caroline O Terranova
• Peninsula Health Cancer Workforce Development - Seleena Sherwell
• Development of a Qstream Knowledge Translation Program on Gynaecological Cancer Care for Advanced Trainees in Oncology - David J Palmieri
• A retrospective analysis of Queensland patients with breast carcinoma with regards to relative frequency of axillary metastases depending on quadrant location of lesion - Shivanthi Kandiah
• Interfacing specialists: clinicians and ICT - Maree A Bransdon
• Patients’ and Carers’ Preferences Regarding the Role of Rehabilitation following Oesophagectomy: A Qualitative Study - Jeff Bull
• Developing an integrated framework to evaluate quality in cancer care - Kim-Lin Chiew
• Supporting best practice shared follow-up care for early breast cancer in Australia: a partnership in delivering a new model of care - Carolyn Der Vartanian
• Breast cancer surgical indicators in Queensland: variations in practice - Nathan Dunn
• Senior Medical Oncology Clinic Audit - Examining the initial experience and geriatric assessment data from the commencement of the Senior Medical Oncology Clinic, at Gold Coast University Hospital. - Gauri Gogna
• Trastuzumab in HER2 positive early breast cancer: A retrospective audit in a regional cancer centre - Sharon Heng
• COMPARISON STUDY OF INTEGRATIVE MEDICINE CENTRES IN AUSTRALIA, U.S.A., AND GERMANY. - Eun Jin Lim
• The National Framework for Gynaecological Cancer Control - Robert Long
• Off the bench: why oncology specialists need to step forward for Lynch syndrome - Beth Fairbank
• A systematic review of comparative effectiveness models and economic evaluations for cancer risk management strategies in BRCA1/2 mutation carriers - Lara Petelin
• Implementing a Framework for Quality Care (Cancer): Optimal Care Pathways - Marita Reed
• The utility of the Medical Oncology Morbidity and Mortality Review process. A tertiary teaching hospital experience - Amitesh Roy
• Implementation of the Medication Management Plan (MMP) in Private Day Oncology Hospitals - Miranda King
• Trials and Tribulations of a Regional Oncology Clinical Trials Unit - Zee Wan Wong
• Consumer Involvement in Research (CIR): Does it work? An Evaluation of Cancer Voices' CIR Program - Elisabeth Kochman
• Unplanned Admissions to a Medical Oncology Unit at a Tertiary Hospital – an Analysis of Emergency Presentations - Ben Gunawan
• Partnering with a local community health organisation to provide rehabilitation to cancer survivors - Meron Pitcher
• Diagnosis, Management and Outcomes of Four Major Cancer Types in a Regional Victorian Health Service - Zee Wan Wong
• Malnutrition risk in head and neck cancer patients at diagnosis. Is it prevalent? - Jessica Abbott
• Meeting the unique information and support needs of Australians diagnosed with de novo metastatic breast cancer - Jenny Anderson
• Evaluating the impact of a cancer council operated wig service for patients experiencing cancer related hair loss - Katherine Lane
• A study into the safety, efficacy and tolerability of scalp cooling in patients receiving chemotherapy, through the reduction of chemotherapy induced alopecia. - Vicki Durston
• Work after cancer – a qualitative study of survivors and health care providers. - Bogda Koczwara
• Rib pain in the management of breast oedema and fibrosis - Teresa S Lee
• The supportive care needs of prostate cancer survivors and their partners – lessons for nurses - Kevin O'Shaughnessy
• Association between communication about cancer care and psychological distress, patient’s symptom and interference with aspect of patient’s life. - Megumi Uchida
• Changes in household income levels after a cancer diagnosis and treatment: Initial results from a pilot study at a single cancer centre. - Anupriya Agarwal
• ASCOLT: Aspirin for Dukes B and High Risk Dukes C Colorectal Cancers - Cheryl Friend
• Systemic anti-cancer therapy in the last 30 days of life: interim results from a regional cancer centre - Ian McPherson

• Oncology rehabilitation in Australia, 'why isn't it standard practice?': a mixed methods study? - Amy M Dennett
• The influence of exercise intensity and frequency on cardiorespiratory fitness and body composition in colorectal cancer survivors: a randomised controlled trial - James L Devin
• Head and Neck Cancer Patient Education and Support Needs - A multi-institution patient survey - Haryana M Dhillon
• Context impacts outcomes: lessons learnt from the South Australian Survivorship Framework pilot implementation - Tracey Doherty
• Physical and psychological health status of breast cancer survivors following primary adjuvant treatment - Sim Yee (Cindy) Tan

• Timeliness of Management for Non-Small Cell Lung Cancer Patients in South Western Sydney - Amrita Chandra
• Breast reconstruction following mastectomy in NSW, 2008-11 - Amy K Johnston
• Treatment and outcomes of metastatic colorectal cancer patients in public and private hospitals: Results from the South Australian Metastatic Colorectal Cancer Registry - Amitesh Roy
• Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at moderate and high risk of breast cancer - Sarah Sutherland
• Adherence to endocrine therapy in a real world cohort of women with early breast cancer treated at two Sydney cancer centres. - Sara SW Wahlroos

• Breast cancer-related lymphedema: incidence and risk factors - Sandi Hayes
• Monitoring for the Early Detection of Breast Cancer Related Lymphoedema: A proactive approach to early detection, assessment and management - Louise A Koelmeyer
• Surgical approaches for the management of lymphoedema - John Boyages
• The lived experience of breast cancer-related lymphoedema - Jane Turner
• Facilitating lymphoedema detection and management through telehealth - Anna Finnane

5:15 PM Panel Discussion

• The Rekindle Study: an Australian randomised phase II study assessing feasibility of an online intervention to promote sexual wellbeing for both cancer survivors and their partners   - Haryana M Dhillon
• Outcomes of the iCanADAPT Program: an internet-based CBT program for depression and anxiety in early stage cancer and cancer survivors - Jill Newby
• Finding My Way: A Web-Based Psychosocial Intervention For Cancer Related Distress - An Outcomes Analysis Of A Multicentre RCT. - Lisa Beatty
• PROMPT-Care: An eHealth decision-support system utilising patient reported outcomes to support patient-centred care and self-management - Geoff Delaney

5:00 PM Q&A panel discussion

• When to do what:  optimizing decisions and outcomes from breast surgery - Laura Esserman
• Psychosocial aspects associated with breast reconstruction - Amanda Fairclough
• Implants and MRI assessment - Michelle Reintals
• Considering Breast Reconstruction with Chemoradiotherapy - Lily Vrtik

5:15 PM Panel discussion

• A validated e-tablet based brief screening tool for psychological distress and fatigue in haematology patients - Stephen Hansen
• Advance care planning increases communication between cancer patients, their oncologists and their family: an RCT - Martin NH Tattersall
• Routine screening and management of anxiety and depression in adult cancer patients: Development of an on-line communication skills education program for health professionals - Joanne Shaw
• Impact of a 12-week online-instructed exercise program in men with breast cancer: Preliminary results of the BRECA-Male-Study - Eva Zopf

• A randomised controlled trial (RCT) of a psychological intervention (Conquer Fear) to reduce clinical levels of fear of cancer recurrence in breast, colorectal and melanoma cancer survivors - Jane Turner
• Breast and ovarian cancer prevention: is it time for population-based genetic testing for BRCA mutations? - Ian G Campbell
• The development of personalised diagnostic tests and therapeutic strategies in breast cancer - Jamie R Kutasovic
• Breast cancer and metastasis: New insights into cell death pathways - Delphine Merino
• Uptake of adjuvant breast cancer treatments recommended by Multi-Disciplinary Meetings - Melinda Pattanasri
• Feasibility of "prehabilitation" in men with prostate cancer undergoing prostatectomy. - Favil Singh

Including the Tom Reeve Oration – Fran Boyle

and ANZBCTG Awards